Quanterix To Report Third Quarter 2024 Financial Results on November 12, 2024
06 November 2024 - 8:00AM
Business Wire
Quanterix Corporation (NASDAQ: QTRX), a company fueling
scientific discovery through ultrasensitive biomarker detection,
today announced that it will host a conference call on Tuesday,
November 12, 2024, at 4:30 p.m. E.T., to discuss third quarter 2024
financial results.
Quanterix will issue a press release regarding third quarter
2024 financial results prior to the conference call on Tuesday,
November 12, 2024, after the market closes. The press release will
be posted on the Quanterix website at
https://www.quanterix.com/.
To pre-register for the conference call with a webcast link
click here. For audio use the following dial-in number and
passcode: USA & Canada - Toll-Free (800) 715-9871 Conference
ID: 2720617. Interested investors can also access the live webcast
from the News & Events page within the Investors section of the
Quanterix website at http://www.quanterix.com. An archived webcast
replay will be available on the Company’s website for one year.
About Quanterix
From discovery to diagnostics, Quanterix’s ultrasensitive
biomarker detection is fueling breakthroughs only made possible
through its unparalleled sensitivity and flexibility. The Company’s
Simoa® technology has delivered the gold standard for earlier
biomarker detection in blood, serum or plasma, with the ability to
quantify proteins that are far lower than the Level of
Quantification (LoQ). Its industry-leading precision instruments,
digital immunoassay technology and CLIA-certified Accelerator
laboratory have supported research that advances disease
understanding and management in neurology, oncology, immunology,
cardiology and infectious disease. Quanterix has been a trusted
partner of the scientific community for nearly two decades,
powering research published in more than 3,100 peer-reviewed
journals. Find additional information about the Billerica,
Massachusetts-based company at https://www.quanterix.com or follow
us on Twitter and LinkedIn.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. Words such as "may," "will," "expect," "plan," "anticipate,"
"estimate," "intend" and similar expressions (as well as other
words or expressions referencing future events, conditions or
circumstances) are intended to identify forward-looking statements.
Forward-looking statements in this news release are based on
Quanterix’ expectations and assumptions as of the date of this
press release. Each of these forward-looking statements involves
risks and uncertainties. Factors that may cause Quanterix’ actual
results to differ from those expressed or implied in the
forward-looking statements in this press release are discussed in
Quanterix’ filings with the U.S. Securities and Exchange
Commission, including the "Risk Factors" sections contained
therein. Except as required by law, Quanterix assumes no obligation
to update any forward-looking statements contained herein to
reflect any change in expectations, even as new information becomes
available.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241105557132/en/
Media: Marissa Klaassen (978) 488-1854
media@quanterix.com
Investor Relations: Amy Achorn (978) 488-1854
ir@quanterix.com
Quanterix (NASDAQ:QTRX)
Historical Stock Chart
From Oct 2024 to Nov 2024
Quanterix (NASDAQ:QTRX)
Historical Stock Chart
From Nov 2023 to Nov 2024